Simon Morriss | Chief Executive Officer |
Mike Tonroe | Chief Financial Officer |
Dr. George Muchnik | Non-Executive Director and Medical Advisor |
Hello and welcome to our Quarter Three business update. I'm Mike Tonroe, Chief Financial Officer Genetic Technologies. I'm also your house and moderator. Thank you for taking the time to join us today. There will be a presentation with a focus on our quarter three results ending 31st of March 2022, and our plans for the next six months, followed by a Q and A session.